Repaglinide

Overview

Repaglinide is an oral medication used to manage Type 2 diabetes mellitus by stimulating the release of insulin from pancreatic beta cells. It is classified as a meglitinide and helps control blood sugar levels post-prandially.

API suppliers (17)

Suppliers of Repaglinide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• JUBILANT BIOSYS LTDIndia1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF GMP on record
• CHROMO LABORATORIES INDIA PRIVATE LTDIndia1 active DMF
• USV PRIVATE LTDIndia1 active DMF GMP on record
• TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTDChina1 active DMF
• Biocon LimitedIndia1 active DMF
• BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGGermany1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
• Zhejiang Hisoar Pharmaceutical Co., Ltd.China
• CHEMWERTH INCFrance
• RANBAXY LABORATORIES LTD
• ACTAVIS GROUP PTC EHFIcelandCEP GMP on record
• ZAKLADY FARMACEUTYCZNE POLPHARMA SA
• ASYMCHEM LIFE SCIENCE TIANJIN CO LTDChina GMP on record

EU CEP holders (10)

Companies holding a valid EU Certificate of Suitability (CEP) for Repaglinide, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas